![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/20 | |
A61K 9/50 | |||
A61K 31/436 |
(11) | Number of the document | 2763663 |
(13) | Kind of document | T |
(96) | European patent application number | 12766990.1 |
Date of filing the European patent application | 2012-10-03 | |
(97) | Date of publication of the European application | 2014-08-13 |
(45) | Date of publication and mention of the grant of the patent | 2017-12-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2012/069541 |
Date | 2012-10-03 |
(87) | Number | WO 2013/050419 |
Date | 2013-04-11 |
(30) | Number | Date | Country code |
201161544026 P | 2011-10-06 | US |
(72) |
DIEDERICH, Anke, CH
LIECHTI, Kurt, CH
KUEHL, Peter, CH
CHEUNG, Wing, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN |
PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN |